CGEN

Compugen Ltd

$2.46 -6.46%

Recent alerts on CGEN

All signals →

News Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

News CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

News Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal

News Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

News Cogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting

News Bayer's (BAYRY) AskBio Advances Parkinson Disease Study

News Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals

News Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals

News Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals

News Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up

News ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag

News Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study

News Annexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals

News Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag

News Intellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data

News Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

News Compugen GAAP EPS of -$0.08 misses by $0.01, revenue of $2.18M beats by $0.92M

News Quant snapshot: Baozun, Sohu among top-rated names as Sol Strategies, Arqit Quantum lag

Insider trade Sale by Zurit Levine (SVP, Business Development)

Insider trade Sale by Eran Ophir (President and CEO)

Insider trade Sale by Zurit Levine (SVP, Business Development)

Insider trade Sale by Eran Ophir (President and CEO)

Insider trade Sale by Zurit Levine (SVP, Business Development)

Insider trade Sale by Zurit Levine (SVP, Business Development)

Insider trade Sale by Zurit Levine (SVP, Business Development)

Get push alerts for CGEN

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS